RIMS Cognitive Manual now available on our website!

rims cognitive manual
Dear RIMS supporter,

A long-term mission of RIMS is that people with MS throughout and across Europe have access to evidence based rehabilitation when they need it.

We are delighted therefore to inform you about the completion of the cognitive manual, which can be downloaded by clicking the button below!

RIMS will continue to provide the MS health care worker with a high quality of evidence-based materials for continued education and practice.

Download!

RIMS Grant Program (RiGra) updated!

The RIMS Grant Program page has been updated for 2014!

Click here to go to the RiGra page immediately.

AAN guideline on CAM in MS -- more on dissemination

The American Academy for Neurology has published guidelines on complimentary and alternative medicine in Multiple Sclerosis. For the evidence-based guidelines, click the thumbnails below!

 

Cam in_MS_CSCam in_MS_CS

                       CAM in MS CS                          CAM in MS PS

Cognitive manual added in SIG Psychology & Neuropsychology section

The cognitive manual - "Good neuropsychological practice in MS" is now available in the SIG Psychology & Neuropsychology section.

Go to the SIG section - Psychology & Neuropsychology - publications or click HERE to go directly to the page.  

PeerVoice ECTRIMS Programme

Rehabilitation, both physical and neuropsychological, is one of the most important aspects of multiple sclerosis (MS) management and a key way to influence outcomes in our patients, beyond pharmacotherapy. Recent advances have allowed us to fine-tune our methods and our assessment tools for rehabilitation in MS. “Beyond Pharmaceuticals: Improving Physical and Mental Function in People With MS” is an educational activity that highlights recent data on this topic presented at the joint 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis and 18th Annual Conference of Rehabilitation in MS (ECTRIMS/RIMS 2013).

Keeping abreast of these updates and integrating these new strategies into our practice may allow us to delay physical and neuropsychological dysfunction in this population. Join me and our expert speakers—Jürg Kesselring, MD, Päivi Hämäläinen, PhD, and Ulrik Dalgas, PhD—as we take a closer look at these recent advances and how they may impact our practice.

join button_small

Rims General Newsletter

Keep informed of news, events and recent publications at EURIMS by subscribing to our newsletter below.
Antispam

Sponsors

  • Logo Merck - Serono
  • Logo Biogen
  • Logo Teva
  • Logo Ectrims
  • Logo Novartis
  • Logo Sanofi - Genzyme